Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18586379 | 0.95 | L3MBTL1 (0.40) | L3MBTL1 | |
| SCHEMBL25403222 | 0.93 | L3MBTL1 (0.39) | L3MBTL1 | |
| SCHEMBL1197473 | 0.89 | L3MBTL1 (0.51) | L3MBTL1MAPTTDP1KDM4EALDH1A1 | |
| SCHEMBL3321417 | 0.82 | PDK2 (0.36) | L3MBTL1MAPTTDP1ALDH1A1HDAC2 | |
| SCHEMBL125993 | 0.81 | — | — | |
| SCHEMBL24346253 | 0.79 | L3MBTL1 (0.36) | L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL122032 | 0.78 | KIT (0.36) | L3MBTL1MAPTTDP1HDAC1HDAC2 | |
| SCHEMBL1436338 | 0.78 | PSD (0.34) | L3MBTL1HDAC2 | |
| SCHEMBL31115874 | 0.78 | MAPT (0.33) | L3MBTL1MAPTTDP1HDAC2 | |
| SCHEMBL4416507 | 0.77 | PTGER4 (0.38) | L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103772282-B | A kind of preparation method of the 3-tertiary butyl-1H-pyrazoles-4-formaldehyde | SHANGHAI BEPHARM CO., LTD. (CN) | 2015-09-23 | — | — | CN | claimed |
| CN-103772282-A | Method for preparing 3-tertiary butyl-1H-pyrazole-4-formaldehyde | BIDE PHARMATECH LTD | 2014-05-07 | — | — | CN | claimed |
| US-12181833-B2 | Photoresponsive polymer | Konica Minolta, Inc. (JP) | 2024-12-31 | — | — | US | disclosed |
| US-11762276-B2 | Photoresponsive compound | Konica Minolta, Inc. (JP) | 2023-09-19 | — | — | US | disclosed |
| US-20220043333-A1 | PHOTORESPONSIVE COMPOUND | Konica Minolta, Inc. (JP) | 2022-02-10 | — | — | US | disclosed |
| CN-108137513-A | Pyrimidine derivatives | ASKA 制药株式会社 | 2018-06-08 | — | — | CN | disclosed |
| US-9707205-B2 | S1P receptors modulators and their use thereof | AKAAL PHARMA PTY LTD. (AU) | 2017-07-18 | — | — | US | disclosed |
| CN-102186845-B | S1P receptor modulators and their purposes | 阿卡制药有限公司 | 2016-09-07 | — | — | CN | disclosed |
| EP-2344484-B1 | S1P RECEPTORS MODULATORS AND USE THEREOF | AKAAL PHARMA PTY LTD (AU) | 2016-06-08 | — | — | EP | disclosed |
| US-20160038455-A1 | S1P RECEPTORS MODULATORS AND THEIR USE THEREOF | AKAAL PHARMA PTY LTD. (AU) | 2016-02-11 | — | — | US | disclosed |
| US-9193716-B2 | S1P receptors modulators and their use thereof | AKAAL PHARMA PTY LTD. (AU) | 2015-11-24 | — | — | US | disclosed |
| US-20140066427-A1 | S1P Receptors Modulators and Their Use Thereof | AKAAL PHARMA PTY LTD. (AU) | 2014-03-06 | — | — | US | disclosed |
| US-8592399-B2 | S1P receptors modulators and their use thereof | AKAAL PHARMA PTY LTD. (AU) | 2013-11-26 | — | — | US | disclosed |
| CN-101484448-B | Pyrazole alkanamide substituted thiophenes as AMPA potentiators | ORGANON NV | 2012-03-14 | — | — | CN | disclosed |
| US-20110318388-A1 | S1P Receptors Modulators and Their Use Thereof | AKAAL PHARMA PTY LTD (AU) | 2011-12-29 | — | — | US | disclosed |
| CN-102186845-A | S1p receptors modulators and their use thereof | AKAAL PHARMA PTY LTD | 2011-09-14 | — | — | CN | disclosed |
| EP-2344484-A1 | S1P RECEPTORS MODULATORS AND THEIR USE THEREOF | Akaal Pharma Pty Ltd (AU) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010043000-A1 | S1P RECEPTORS MODULATORS AND THEIR USE THEREOF | AKAAL PHARMA PTY LTD (AU) | 2010-04-22 | — | — | WO | disclosed |
| CN-101687790-A | Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2(MGLU2 receptor) | ABBOTT GMBH & CO KG | 2010-03-31 | — | — | CN | disclosed |
| CN-101484448-A | Pyrazolealkanamide substituted thiophenes as AMPA potentiators | ORGANON NV (NL) | 2009-07-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160038455-A1 | S1P RECEPTORS MODULATORS AND THEIR USE THEREOF | S1PR1, S1PR5, S1PR2 | L3MBTL1 3695/4885CTSD 2766/4885BACE1 1353/4885 |
| US-20110318388-A1 | S1P Receptors Modulators and Their Use Thereof | S1PR1, S1PR5, S1PR2 | L3MBTL1 3695/4885CTSD 2766/4885BACE1 1353/4885 |
| US-20140066427-A1 | S1P Receptors Modulators and Their Use Thereof | S1PR1, S1PR2, S1PR5 | L3MBTL1 4256/4885CTSD 2986/4885BACE1 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.